Sector Update: Healthcare – Video

Posted by Dr. Michael White, Published on November 2nd, 2012
()


Sector Update: Healthcare
Shares of healthcare companies are lower ahead of the bell with Johnson Johnson (JNJ) and AstraZeneca Plc (AZN) reportedly stopping studies of experimental painkillers over concerns the new class of drugs may raise the risk of joint damage, Bloomberg reports. Endo Pharmaceutical Holdings (ENDP) said US regulators have approved its Fortesta gel as a treatment for hypogonadism or low testosterone. The company expects to launch Fortesta in the US early next year. St. Jude Medical (STJ) said it secured a new, $1.5 billion credit agreement with a group of lenders led by Bank of America (BAC), replacing a $1 billion loan package established in December 2006 used for general corporate purposes and to support its commercial paper program. Borrowing under the new pact running through 2015 will bear interest at LIBOR plus 0.875%, subject to revision if there #39;s a change in St. Jude #39;s credit rating.From:FinancialNewsOnlineViews:228 3ratingsTime:01:07More inNews Politics

View original post here:

Sector Update: Healthcare - Video

Contact Us Today


Name (*):

Email (*):

Phone (*):

Program (*):

State (*):

Age (30+ only):

(*) - Required



herbs specialist that levels increase testosterone.webp


Related Post

How useful was this post?

Click on a smiley face to rate it!

Average rating / 5. Vote count:

No votes so far! Be the first to rate this post.

Word Count: 167

Comments are closed.



tongkat testosterone chart ali.webp
what are the effects of low testosterone levels.webp
physical symptoms of low